Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Glycerin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.35 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.35 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL27232528 | 1.00 | LMNA (0.60) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL5903136 | 1.00 | LMNA (0.60) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL30710214 | 0.97 | LMNA (0.64) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL188342 | 0.97 | LMNA (0.64) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL21101 | 0.97 | LMNA (0.64) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL579432 | 0.97 | LMNA (0.64) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL888512 | 0.97 | LMNA (0.64) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL31106042 | 0.97 | LMNA (0.64) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL14482185 | 0.93 | LMNA (0.60) | LMNAALDH1A1THRBGABRR1GABBR2 | |
| Glycerin SCHEMBL1792712 | 0.93 | LMNA (0.60) | LMNAALDH1A1THRBGABRR1GABBR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 427 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4432862-A1 | ORAL PRODUCTS WITH NICOTINE-POLYMER COMPLEX | Nicoventures Trading Limited (GB) | 2024-09-25 | — | — | EP | claimed |
| EP-4188338-A1 | BILAYER TABLET COMPRISING EZETIMIBE AND ATORVASTATIN | KRKA, d.d., Novo mesto (SI) | 2023-06-07 | — | — | EP | claimed |
| WO-2023084498-A1 | ORAL PRODUCTS WITH NICOTINE-POLYMER COMPLEX | Nicoventures Trading Limited (GB) | 2023-05-19 | — | — | WO | claimed |
| US-20230148652-A1 | ORAL PRODUCTS WITH NICOTINE-POLYMER COMPLEX | NICOVENTURES TRADING LTD (GB) | 2023-05-18 | — | — | US | claimed |
| WO-2022023206-A1 | BILAYER TABLET COMPRISING EZETIMIBE AND ATORVASTATIN | KRKA, D.D., NOVO MESTO (SI) | 2022-02-03 | — | — | WO | claimed |
| WO-2021072139-A1 | FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-04-15 | — | — | WO | claimed |
| WO-2020139237-A2 | A BILAYER TABLET FORMULATION OF ATORVASTATIN CALCIUM AND EZETIMIBE | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2020-07-02 | — | — | WO | claimed |
| US-20180311298-A1 | Composition, and Method of Using the Composition, Effective for Minimizing the Harmful Effects Associated With Individuals Suffering from Alcohol Intoxication | BURN-OFF, LLC | 2018-11-01 | — | — | US | claimed |
| WO-2018146302-A1 | PHARMACEUTICAL BILAYER TABLET COMPOSITION OF ATORVASTATIN CALCIUM AND EZETIMIBE | SANOVEL ILAC SANAYI VE TICARET A.S. (TR) | 2018-08-16 | — | — | WO | claimed |
| EP-3330310-A1 | HYDROGEL COMPOSITE MATERIAL | Technische Universität Dortmund (DE) | 2018-06-06 | — | — | EP | claimed |
| US-9186350-B2 | Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication | GDB PATENT HOLDINGS, LLC (US) | 2015-11-17 | — | — | US | claimed |
| WO-2013009997-A1 | COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATED WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION | BURN-OFF, LLC (US) | 2013-01-17 | — | — | WO | claimed |
| US-20130017276-A1 | Composition, and Method of Using the Composition, Effective for Minimizing the Harmful Effects Associated with Individuals Suffering from Alcohol Intoxication | GDB PATENT HOLDINGS, LLC | 2013-01-17 | — | — | US | claimed |
| US-20120165236-A1 | CLEANSING AGENT | SHOICHI NAKAMURA (JP) | 2012-06-28 | — | — | US | claimed |
| WO-2006135601-A1 | COMPOSITION FOR THE MINERALIZATION OF DENTAL HARD TISSUES AND THE REDUCTION OF CARIES-INDUCIVE MICROFLORA | PELDYAK JOHN (US) | 2006-12-21 | — | — | WO | claimed |
| US-20060280694-A1 | Composition for the mineralization of dental hard tissues and the reduction of caries-inducive microflora | PELDYAK JOHN | 2006-12-14 | — | — | US | claimed |
| US-20060275223-A1 | Erythritol compositions for teeth and gums | XLEAR, INC. | 2006-12-07 | — | — | US | claimed |
| WO-2004098294-A1 | DOUGH ADDITIVE | BRECHET & RICHTER COMPANY (US) | 2004-11-18 | — | — | WO | claimed |
| US-20030180414-A1 | Method of controlling release of bitterness inhibitors in chewing gum and gum produced thereby | WM. WRIGLEY JR. COMPANY | 2003-09-25 | — | — | US | claimed |
| US-12637408-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-26 | — | — | US | disclosed |
| US-20260132353-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-14 | — | — | US | disclosed |
| US-20260117315-A1 | KEY PREDOMINANT SPECIES OF GUT BACTERIA COLONIZING FARM-EXPOSED INFANTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-12529007-B2 | Lipid comprising docosapentaenoic | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-01-20 | — | — | US | disclosed |
| US-12492354-B2 | Lipid comprising docosapentaenoic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2025-12-09 | — | — | US | disclosed |
| US-20250160380-A1 | NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE | MEAD JOHNSON NUTRITION COMPANY (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250151768-A1 | Nutritional Compositions | GAMBLE MARDELLE HELEN (CA) | 2025-05-15 | — | — | US | disclosed |
| US-20250134122-A1 | PEDIATRIC NUTRITIONAL COMPOSITIONS AND METHODS FOR INFANTS DELIVERED BY C-SECTION | MEAD JOHNSON NUTRITION CO (US) | 2025-05-01 | — | — | US | disclosed |
| US-20250064555-A1 | Hardenable Dental Compositions Comprising Basic Core Material Encapsulated in an Inorganic Shell and Dispensing Devices Therewith | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-02-27 | — | — | US | disclosed |
| US-20240423755-A1 | Two-Part Dental Sealant, Method of Applying with a Syringe Device, and Kit | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-12-26 | — | — | US | disclosed |
| US-12161523-B2 | Hardenable dental compositions comprising basic core material encapsulated in an inorganic shell and dispensing devices therewith | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-12-10 | — | — | US | disclosed |
| US-12102499-B2 | Two-part dental sealant, method of applying with a syringe device, and kit | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-10-01 | — | — | US | disclosed |
| EP-4432862-A1 | ORAL PRODUCTS WITH NICOTINE-POLYMER COMPLEX | Nicoventures Trading Limited (GB) | 2024-09-25 | — | — | EP | disclosed |
| US-12053008-B2 | Microwavable frozen dumplings and methods thereof | AJINOMOTO CO., INC. (JP) | 2024-08-06 | — | — | US | disclosed |
| US-20240188617-A1 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | MEAD JOHNSON NUTRITION CO (US) | 2024-06-13 | — | — | US | disclosed |
| US-20230416186-A1 | LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-12-28 | — | — | US | disclosed |
| US-20230404129-A1 | Infant Formula Having Decreased Protein Content | MEAD JOHNSON NUTRITION COMPANY | 2023-12-21 | — | — | US | disclosed |
| WO-2023228574-A1 | PLANT-BASED MEAT MIMETICS | AJINOMOTO CO., INC. (JP) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023228575-A1 | PLANT PROTEIN-BASED FOOD BINDER | AJINOMOTO CO., INC. (JP) | 2023-11-30 | — | — | WO | disclosed |
| US-20230348357-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-11-02 | — | — | US | disclosed |
| US-11785976-B2 | Protein hydrolysates and methods of making same | MEAD JOHNSON NUTRITION COMPANY (US) | 2023-10-17 | — | — | US | disclosed |
| EP-3525604-B1 | PERSONALIZED PEDIATRIC NUTRITION PRODUCTS COMPRISING HUMAN MILK OLIGOSACCHARIDES | MJN US HOLDINGS LLC (US) | 2023-09-27 | — | — | EP | disclosed |
| US-11718577-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-08-08 | — | — | US | disclosed |
| US-20230219879-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-07-13 | — | — | US | disclosed |
| US-20230189850-A1 | MICROWAVABLE FROZEN STEAMED DUMPLINGS AND METHODS THEREOF | AJINOMOTO CO., INC. (JP) | 2023-06-22 | — | — | US | disclosed |
| EP-4188338-A1 | BILAYER TABLET COMPRISING EZETIMIBE AND ATORVASTATIN | KRKA, d.d., Novo mesto (SI) | 2023-06-07 | — | — | EP | disclosed |
| WO-2023084498-A1 | ORAL PRODUCTS WITH NICOTINE-POLYMER COMPLEX | Nicoventures Trading Limited (GB) | 2023-05-19 | — | — | WO | disclosed |
| US-20230148652-A1 | ORAL PRODUCTS WITH NICOTINE-POLYMER COMPLEX | NICOVENTURES TRADING LTD (GB) | 2023-05-18 | — | — | US | disclosed |
| US-11647778-B2 | Nutritional compositions containing milk-derived peptides and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2023-05-16 | — | — | US | disclosed |
| US-20230134622-A1 | TWO-PART DENTAL SEALANT, METHOD OF APPLYING WITH A SYRINGE DEVICE, AND KIT | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-05-04 | — | — | US | disclosed |
| US-20230120190-A1 | ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR FULL MAINTENANCE OF ORAL HEALTH, PROCESS FOR OBTAINING AND USES THEREOF | TEIXEIRA MARCELO RODRIGUES (BR) | 2023-04-20 | — | — | US | disclosed |
| EP-3352583-B1 | INFANT FORMULA TABLETS | MJN US HOLDINGS LLC (US) | 2023-04-12 | — | — | EP | disclosed |
| US-11623911-B2 | Lipid comprising docosapentaenoic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-04-11 | — | — | US | disclosed |
| US-20230103910-A1 | KEY PREDOMINANT SPECIES OF GUT BACTERIA COLONIZING FARM-EXPOSED INFANTS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2023-04-06 | — | — | US | disclosed |
| US-11612575-B2 | Combination therapies with disulfiram | Spring Discovery, Inc. (US) | 2023-03-28 | — | — | US | disclosed |
| EP-4098242-A1 | ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR COMPLETE MAINTENANCE OF ORAL HEALTH, METHOD FOR OBTAINING SAME AND USES | Teixeira, Marcelo Rodrigues (BR) | 2022-12-07 | — | — | EP | disclosed |
| EP-4096620-A1 | COMPOSITIONS AND METHODS FOR HAIR | L'Oréal (FR) | 2022-12-07 | — | — | EP | disclosed |
| WO-2022232635-A1 | CELLULAR COMPOSITIONS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2022-11-03 | — | — | WO | disclosed |
| US-20220313778-A1 | NUTRITIONAL COMPOSITIONS | GAMBLE MARDELLE HELEN (CA) | 2022-10-06 | — | — | US | disclosed |
| US-20220232874-A1 | NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE | MEAD JOHNSON NUTRITION COMPANY (US) | 2022-07-28 | — | — | US | disclosed |
| US-20220151268-A1 | MICROWAVABLE FROZEN DUMPLINGS AND METHODS THEREOF | AJINOMOTO CO., INC. (JP) | 2022-05-19 | — | — | US | disclosed |
| EP-3986164-A1 | NUTRITIONAL COMPOSITIONS | Gamble, Mardelle (CA) | 2022-04-27 | — | — | EP | disclosed |
| US-20220110357-A1 | PERSONALIZED PEDIATRIC NUTRITION PRODUCTS COMPRISING HUMAN MILK OLIGOSACCHARIDES | MEAD JOHNSON NUTRITION COMPANY (US) | 2022-04-14 | — | — | US | disclosed |
| US-20220095666-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2022-03-31 | — | — | US | disclosed |
| US-20220087955-A1 | COMBINATION THERAPIES WITH DISULFIRAM | WINTER ACQUISITION SUB, INC. | 2022-03-24 | — | — | US | disclosed |
| WO-2022061171-A1 | COMBINATION THERAPIES WITH DISULFIRAM | Spring Discovery, Inc. (US) | 2022-03-24 | — | — | WO | disclosed |
| US-20220087956-A1 | COMBINATION THERAPIES WITH DISULFIRAM | WINTER ACQUISITION SUB, INC. | 2022-03-24 | — | — | US | disclosed |
| WO-2022023206-A1 | BILAYER TABLET COMPRISING EZETIMIBE AND ATORVASTATIN | KRKA, D.D., NOVO MESTO (SI) | 2022-02-03 | — | — | WO | disclosed |
| US-20210244784-A1 | COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATE WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION | GDB PATENT HOLDINGS, LLC (US) | 2021-08-12 | — | — | US | disclosed |
| US-20210244787-A9 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | MEAD JOHNSON NUTRITION COMPANY | 2021-08-12 | — | — | US | disclosed |
| US-20210246097-A1 | LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2021-08-12 | — | — | US | disclosed |
| US-20210236404-A1 | COMPOSITIONS AND METHODS FOR HAIR | L'OREAL (FR) | 2021-08-05 | — | — | US | disclosed |
| US-20210235740-A1 | PROTEIN HYDROLYSATES AND METHODS OF MAKING SAME | MEAD JOHNSON NUTRITION COMPANY (US) | 2021-08-05 | — | — | US | disclosed |
| US-20210236398-A1 | COMPOSITIONS AND METHODS FOR HAIR | L'OREAL (FR) | 2021-08-05 | — | — | US | disclosed |
| WO-2021155002-A1 | COMPOSITIONS AND METHODS FOR HAIR | FEREBEE RACHEL (US) | 2021-08-05 | — | — | WO | disclosed |
| WO-2021155007-A1 | COMPOSITIONS COMPRISING A COMPOUND COMPRISING A PHOSPHATE GROUP, AND METHODS FOR PROTECTING HAIR | FEREBEE RACHEL (US) | 2021-08-05 | — | — | WO | disclosed |
| US-11077166-B2 | Nutritional supplements containing a peptide component and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210227845-A1 | PEDIATRIC NUTRITIONAL COMPOSITIONS AND METHODS FOR INFANTS DELIVERED BY C-SECTION | MEAD JOHNSON NUTRITION COMPANY (US) | 2021-07-29 | — | — | US | disclosed |
| US-20210228315-A1 | HARDENABLE DENTAL COMPOSITIONS COMPRISING BASIC CORE MATERIAL ENCAPSULATED IN AN INORGANIC SHELL AND DISPENSING DEVICES THEREWITH | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2021-07-29 | — | — | US | disclosed |
| US-11065214-B1 | Combination therapies with disulfiram | Spring Discovery, Inc. (US) | 2021-07-20 | — | — | US | disclosed |
| US-11033516-B1 | Combination therapies with disulfiram | Spring Discovery, Inc. (US) | 2021-06-15 | — | — | US | disclosed |
| US-11013759-B2 | Compositions for enhancing immune function in a pediatric subject | MEAD JOHNSON NUTRITION COMPANY (US) | 2021-05-25 | — | — | US | disclosed |
| US-10980269-B2 | Protein hydrolysates and methods of making same | MEAD JOHNSON NUTRITION COMPANY (US) | 2021-04-20 | — | — | US | disclosed |
| US-20210106525-A1 | FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2021-04-15 | — | — | US | disclosed |
| WO-2021072139-A1 | FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-04-15 | — | — | WO | disclosed |
| EP-3801360-A1 | HARDENABLE DENTAL COMPOSITIONS COMPRISING BASIC CORE MATERIAL ENCAPSULATED IN AN INORGANIC SHELL AND DISPENSING DEVICES THEREWITH | 3M Innovative Properties Company (US) | 2021-04-14 | — | — | EP | disclosed |
| EP-3801359-A1 | TWO-PART DENTAL SEALANT, METHOD OF APPLYING WITH A SYRINGE DEVICE, AND KIT | 3M Innovative Properties Company (US) | 2021-04-14 | — | — | EP | disclosed |
| EP-3797785-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2021-03-31 | — | — | EP | disclosed |
| EP-3790412-A1 | PEDIATRIC NUTRITIONAL COMPOSITIONS AND METHODS FOR INFANTS DELIVERED BY C-SECTION | MJN U.S. Holdings LLC (US) | 2021-03-17 | — | — | EP | disclosed |
| EP-3790555-A1 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | MJN U.S. Holdings LLC (US) | 2021-03-17 | — | — | EP | disclosed |
| US-10945446-B2 | Nutritional compositions and methods for promoting cognitive development | MEAD JOHNSON NUTRITION COMPANY (US) | 2021-03-16 | — | — | US | disclosed |
| US-20210068439-A1 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | MJN U.S. HOLDINGS LLC (US) | 2021-03-11 | — | — | US | disclosed |
| US-10933114-B2 | Nutritional supplements containing a peptide component and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2021-03-02 | — | — | US | disclosed |
| US-20200404957-A1 | NUTRITIONAL COMPOSITIONS CONTAINING MILK-DERIVED PEPTIDES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2020-12-31 | — | — | US | disclosed |
| WO-2020252576-A1 | NUTRITIONAL COMPOSITIONS | GAMBLE MARDELLE (CA) | 2020-12-24 | — | — | WO | disclosed |
| EP-3735139-A1 | NUTRITIONAL COMPOSITIONS CONTAINING MILK-DERIVED PEPTIDES AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2020-11-11 | — | — | EP | disclosed |
| US-10793507-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-10-06 | — | — | US | disclosed |
| US-20200260773-A1 | Infant Formula Having Decreased Protein Content | MEAD JOHNSON NUTRITION COMPANY | 2020-08-20 | — | — | US | disclosed |
| EP-2986164-B1 | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | MJN US HOLDINGS LLC (US) | 2020-07-29 | — | — | EP | disclosed |
| US-20200222436-A1 | Nutritional Composition With Human Milk Oligosaccharides And Uses Thereof | MEAD JOHNSON NUTRITION COMPANY | 2020-07-16 | — | — | US | disclosed |
| EP-3678491-A1 | INFANT FORMULA HAVING DECREASED PROTEIN CONTENT | MJN U.S. Holdings LLC (US) | 2020-07-15 | — | — | EP | disclosed |
| US-10709770-B2 | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2020-07-14 | — | — | US | disclosed |
| WO-2020139237-A2 | A BILAYER TABLET FORMULATION OF ATORVASTATIN CALCIUM AND EZETIMIBE | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2020-07-02 | — | — | WO | disclosed |
| US-20200163354-A1 | Nutritional Compositions And Methods For Promoting Cognitive Development | MEAD JOHNSON NUTRITION COMPANY | 2020-05-28 | — | — | US | disclosed |
| US-10639334-B2 | Pediatric nutritional composition with milk peptides for healthy growth and development | MEAD JOHNSON NUTRITION COMPANY (US) | 2020-05-05 | — | — | US | disclosed |
| US-10617701-B2 | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid | MEAD JOHNSON NUTRITION COMPANY (US) | 2020-04-14 | — | — | US | disclosed |
| EP-3624601-A1 | PRETERM INFANT FORMULA CONTAINING BUTYRATE AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2020-03-25 | — | — | EP | disclosed |
| US-20200085762-A1 | Nutritional Compositions Containing An Elevated Level Of Inositol And Uses Thereof | MEAD JOHNSON NUTRITION COMPANY | 2020-03-19 | — | — | US | disclosed |
| US-10590055-B2 | Glycerol derived material | BIO-ENERGY INGREDIENTS LIMITED (GB) | 2020-03-17 | — | — | US | disclosed |
| US-10582714-B2 | Nutritional compositions and methods for promoting cognitive development | MEAD JOHNSON NUTRITION COMPANY (US) | 2020-03-10 | — | — | US | disclosed |
| CN-110494098-A | Electrolyte composition containing metal and silicon in plasma electrolysis oxidation process and the dental that the hydroxyapatite containing metal ion and silicon ion is coated with using its composition plant the manufacturing method of tooth | UNIV CHOSUN IACF | 2019-11-22 | — | — | CN | disclosed |
| WO-2019215302-A1 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | MJN U.S. HOLDINGS LLC (US) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019215289-A1 | PEDIATRIC NUTRITIONAL COMPOSITIONS AND METHODS FOR INFANTS DELIVERED BY C-SECTION | MJN U.S. HOLDINGS LLC (US) | 2019-11-14 | — | — | WO | disclosed |
| US-10455854-B2 | Nutritional compositions containing structured fat globules and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2019-10-29 | — | — | US | disclosed |
| EP-3550991-A1 | PROTEIN HYDROLYSATES AND METHODS OF MAKING SAME | MJN U.S. Holdings LLC (US) | 2019-10-16 | — | — | EP | disclosed |
| EP-3550992-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2019-10-16 | — | — | EP | disclosed |
| EP-3551217-A2 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND/OR LACTOFERRIN AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2019-10-16 | — | — | EP | disclosed |
| EP-3547988-A1 | BASIC CORE MATERIAL ENCAPSULATED IN AN INORGANIC SHELL SUITABLE FOR USE IN BIOLOGICAL CARRIER MATERIALS | 3M Innovative Properties Company (US) | 2019-10-09 | — | — | EP | disclosed |
| EP-3548057-A1 | METHODS FOR INDUCING ADIPOCYTE BROWNING, IMPROVING METABOLIC FLEXIBILITY, AND REDUCING DETRIMENTAL WHITE ADIPOSE TISSUE DEPOSITION AND DYSFUNCTION | MJN U.S. Holdings LLC (US) | 2019-10-09 | — | — | EP | disclosed |
| EP-3538120-A1 | NUTRITIONAL COMPOSITIONS PROVIDING DIETARY MANAGEMENT OF COLIC | MJN U.S. Holdings LLC (US) | 2019-09-18 | — | — | EP | disclosed |
| EP-2879508-B1 | INFANT FORMULA OR GROWING UP MILK | MJN US HOLDINGS LLC (US) | 2019-08-21 | — | — | EP | disclosed |
| US-20190240283-A1 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | MEAD JOHNSON NUTRITION COMPANY | 2019-08-08 | — | — | US | disclosed |
| EP-2648549-B1 | COMPOSITIONS AND METHODS FOR NUTRIENT DELIVERY | MJN US HOLDINGS LLC (US) | 2019-07-31 | — | — | EP | disclosed |
| US-20190224273-A1 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | MEAD JOHNSON NUTRITION CO (US) | 2019-07-25 | — | — | US | disclosed |
| US-20190208807-A1 | NUTRITIONAL COMPOSITIONS CONTAINING MILK-DERIVED PEPTIDES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2019-07-11 | — | — | US | disclosed |
| WO-2019135084-A1 | NUTRITIONAL COMPOSITIONS CONTAINING MILK-DERIVED PEPTIDES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2019-07-11 | — | — | WO | disclosed |
| US-20190194572-A1 | LIPID COMPRISING DOCOSAPENTAENOIC ACID | NUSEED NUTRITIONAL AUSTRALIA PTY LTD (AU) | 2019-06-27 | — | — | US | disclosed |
| EP-2983531-B1 | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT WITH ANTI-INFLAMMATORY PROPERTIES AND USES THEREOF | MJN US HOLDINGS LLC (US) | 2019-04-24 | — | — | EP | disclosed |
| US-10251928-B2 | Nutritional supplements containing a peptide component and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| WO-2019048490-A1 | INFANT FORMULA HAVING DECREASED PROTEIN CONTENT | MJN U.S. HOLDINGS LLC (US) | 2019-03-14 | — | — | WO | disclosed |
| EP-1771490-B1 | BIOCOMPATIBLE, BIODEGRADABLE POLYURETHANE MATERIALS WITH CONTROLLED HYDROPHOBIC TO HYDROPHILIC RATIO | SYNTHES GMBH (CH) | 2019-01-02 | — | — | EP | disclosed |
| US-20180354888-A1 | LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS AT THE SN-2 POSITION | NUSEED PTY LTD. (AU) | 2018-12-13 | — | — | US | disclosed |
| US-20180332881-A1 | PRETERM INFANT FORMULA CONTAINING BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2018-11-22 | — | — | US | disclosed |
| US-20180333426-A1 | NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2018-11-22 | — | — | US | disclosed |
| WO-2018210805-A1 | PRETERM INFANT FORMULA CONTAINING BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-11-22 | — | — | WO | disclosed |
| WO-2018210807-A1 | NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-11-22 | — | — | WO | disclosed |
| US-10125084-B2 | Lipid comprising docosapentaenoic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-11-13 | — | — | US | disclosed |
| US-20180311298-A1 | Composition, and Method of Using the Composition, Effective for Minimizing the Harmful Effects Associated With Individuals Suffering from Alcohol Intoxication | BURN-OFF, LLC | 2018-11-01 | — | — | US | disclosed |
| EP-1863438-B1 | TOOTH WHITENER | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2018-10-24 | — | — | EP | disclosed |
| EP-2765870-B1 | NUTRITIONAL PHYTONUTRIENT COMPOSITIONS | MJN US HOLDINGS LLC (US) | 2018-10-03 | — | — | EP | disclosed |
| EP-3373749-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3373748-A1 | NUTRITIONAL COMPOSITIONS COMPRISING A CASEIN HYDROLYSATE, AS WELL AS DIETARY BUTYRATE AND/OR A COMPOUND FOR STIMULATING FORMATION OF ENDOGENOUS BUTYRATE | MJN U.S. Holdings LLC (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3373747-A1 | NUTRITIONAL COMPOSITIONS COMPRISING LACTOBACILLUS RHAMNOSUS GG, AS WELL AS DIETARY BUTYRATE AND/OR A COMPOUND FOR STIMULATING FORMATION OF ENDOGENOUS BUTYRATE | MJN U.S. Holdings LLC (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3370548-A1 | NUTRITIONAL COMPOSITIONS FOR PROMOTING GUT BARRIER FUNCTION AND AMELIORATING VISCERAL PAIN | MJN U.S. Holdings LLC (US) | 2018-09-12 | — | — | EP | disclosed |
| US-20180235269-A1 | Nutritional Compositions Containing Structured Fat Globules And Uses Thereof | MEAD JOHNSON NUTRITION CO (US) | 2018-08-23 | — | — | US | disclosed |
| WO-2018146302-A1 | PHARMACEUTICAL BILAYER TABLET COMPOSITION OF ATORVASTATIN CALCIUM AND EZETIMIBE | SANOVEL ILAC SANAYI VE TICARET A.S. (TR) | 2018-08-16 | — | — | WO | disclosed |
| US-10034937-B2 | Synergistic nutritional compositions and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-07-31 | — | — | US | disclosed |
| US-10028991-B2 | Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication | GDB PATENT HOLDINGS, LLC (US) | 2018-07-24 | — | — | US | disclosed |
| US-10028519-B2 | Nutritional compositions containing ceramide and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-07-24 | — | — | US | disclosed |
| WO-2018115019-A1 | NUTRITIONAL COMPOSITIONS CONTAINING INOSITOL AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-06-28 | — | — | WO | disclosed |
| EP-2863761-B1 | DIETARY MANAGEMENT OF CELIAC DISEASE AND FOOD ALLERGY | MJN US HOLDINGS LLC (US) | 2018-06-27 | — | — | EP | disclosed |
| US-10005713-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-06-26 | — | — | US | disclosed |
| WO-2018108931-A2 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND/OR LACTOFERRIN AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-06-21 | — | — | WO | disclosed |
| WO-2018108841-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-06-21 | — | — | WO | disclosed |
| US-20180168215-A1 | NUTRITIONAL COMPOSITIONS CONTAINING INOSITOL AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2018-06-21 | — | — | US | disclosed |
| WO-2018108883-A1 | PROTEIN HYDROLYSATES AND METHODS OF MAKING SAME | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-06-21 | — | — | WO | disclosed |
| US-20180160714-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2018-06-14 | — | — | US | disclosed |
| US-20180161381-A1 | NUTRITIONAL COMPOSITIONS AND METHODS FOR REDUCING THE OCCURRENCE OR SEVERITY OF VIRAL INFECTIONS, BACTERIAL INFECTIONS AND VIRAL AND BACTERIAL CO-INFECTIONS | MEAD JOHNSON NUTRITION COMPANY | 2018-06-14 | — | — | US | disclosed |
| US-20180160715-A1 | PROTEIN HYDROLYSATES AND METHODS OF MAKING SAME | MEAD JOHNSON NUTRITION COMPANY | 2018-06-14 | — | — | US | disclosed |
| WO-2018104248-A1 | METHODS FOR INDUCING ADIPOCYTE BROWNING, IMPROVING METABOLIC FLEXIBILITY, AND REDUCING DETRIMENTAL WHITE ADIPOSE TISSUE DEPOSITION AND DYSFUNCTION | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-06-14 | — | — | WO | disclosed |
| US-20180161292-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2018-06-14 | — | — | US | disclosed |
| WO-2018102484-A1 | BASIC CORE MATERIAL ENCAPSULATED IN AN INORGANIC SHELL SUITABLE FOR USE IN BIOLOGICAL CARRIER MATERIALS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-06-07 | — | — | WO | disclosed |
| US-20180153951-A1 | Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction | MEAD JOHNSON NUTRITION COMPANY | 2018-06-07 | — | — | US | disclosed |
| EP-3330310-A1 | HYDROGEL COMPOSITE MATERIAL | Technische Universität Dortmund (DE) | 2018-06-06 | — | — | EP | disclosed |
| EP-3324991-A1 | NUTRITIONAL COMPOSITIONS COMPRISING HYDROLYSED CASEIN | MJN U.S. Holdings LLC (US) | 2018-05-30 | — | — | EP | disclosed |
| US-9980506-B2 | Nutritional compositions containing structured fat globules and uses thereof | MEAD JOHNSON NUTRITION CO. (US) | 2018-05-29 | — | — | US | disclosed |
| WO-2018086843-A1 | NUTRITIONAL COMPOSITIONS PROVIDING DIETARY MANAGEMENT OF COLIC | MEAD JOHNSON NUTRITION COMPANY (US) | 2018-05-17 | — | — | WO | disclosed |
| US-20180133287-A1 | NUTRITIONAL COMPOSITIONS PROVIDING DIETARY MANAGEMENT OF COLIC | UNIVERSITA CATTOLICA DEL SACRO CUORE (IT) | 2018-05-17 | — | — | US | disclosed |
| EP-3319462-A1 | NUTRITIONAL COMPOSITIONS CONTAINING PHOSPHATIDYLETHANOLAMINE, SPHINGOMYELIN AND DOCOSAHEXAENOIC ACID | MJN U.S. Holdings LLC (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-3319460-A1 | NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT | MJN U.S. Holdings, LLC (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-3319461-A1 | NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT | MJN U.S. Holdings LLC (US) | 2018-05-16 | — | — | EP | disclosed |
| US-20180103675-A1 | PERSONALIZED PEDIATRIC NUTRITION PRODUCTS COMPRISING HUMAN MILK OLIGOSACCHARIDES | MEAD JOHNSON NUTRITION COMPANY | 2018-04-19 | — | — | US | disclosed |
| EP-2934188-B1 | MILK-BASED NUTRITIONAL COMPOSITIONS CONTAINING LACTOFERRIN AND USES THEREOF | MJN US HOLDINGS LLC (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-3302102-A1 | NUTRITIONAL COMPOSITIONS CONTAINING AN ELEVATED LEVEL OF INOSITOL AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2018-04-11 | — | — | EP | disclosed |
| WO-2018048603-A1 | NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2018-03-15 | — | — | WO | disclosed |
| US-20180064739-A1 | NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2018-03-08 | — | — | US | disclosed |
| US-9907323-B2 | Infant formula tablets | MEAD JOHNSON NUTRITION CO. (US) | 2018-03-06 | — | — | US | disclosed |
| EP-2337450-B1 | METHODS FOR PRESERVING ENDOGENOUS TGF-BETA | MJN US HOLDINGS LLC (US) | 2018-02-07 | — | — | EP | disclosed |
| US-20170360855-A1 | NUTRITIONAL COMPOSITIONS FOR PROMOTING GUT BARRIER FUNCTION AND AMELIORATING VISCERAL PAIN | MEAD JOHNSON NUTRITION COMPANY | 2017-12-21 | — | — | US | disclosed |
| US-20170305834-A1 | LIPID COMPRISING DOCOSAPENTAENOIC ACID | NUSEED NUTRITIONAL AUSTRALIA PTY LTD (AU) | 2017-10-26 | — | — | US | disclosed |
| EP-2943081-B1 | NUTRITIONAL COMPOSITIONS CONTAINING MAGNESIUM THREONATE AND USES THEREOF | MJN US HOLDINGS LLC (US) | 2017-10-04 | — | — | EP | disclosed |
| EP-3214953-A1 | NUTRITIONAL SUPPLEMENTS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2017-09-13 | — | — | EP | disclosed |
| EP-3214951-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRIN AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2017-09-13 | — | — | EP | disclosed |
| US-9737089-B2 | Milk-based nutritional compositions containing lactoferrin and uses thereof | MEAD JOHNSON NUTRITION COMPANY | 2017-08-22 | — | — | US | disclosed |
| US-20170231262-A1 | NUTRITIONAL COMPOSITIONS CONTAINING STRUCTURED FAT GLOBULES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2017-08-17 | — | — | US | disclosed |
| US-9730969-B2 | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain | MEAD JOHNSON NUTRITION COMPANY | 2017-08-15 | — | — | US | disclosed |
| EP-3200620-A1 | NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE | MJN U.S. Holdings, LLC (US) | 2017-08-09 | — | — | EP | disclosed |
| US-20170215464-A1 | NUTRITIONAL COMPOSITIONS CONTAINING DIETARY BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2017-08-03 | — | — | US | disclosed |
| US-9718759-B2 | Lipid comprising docosapentaenoic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-08-01 | — | — | US | disclosed |
| EP-2765871-B1 | COMPOSITION AND METHOD OF PHYTONUTRIENTS FOR METABOLIC PROGRAMMING EFFECTS | MJN US HOLDINGS LLC (US) | 2017-07-26 | — | — | EP | disclosed |
| US-20170157242-A1 | SYNERGISTIC NUTRITIONAL COMPOSITIONS AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-9661874-B2 | Nutritional compositions containing structured fat globules and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2017-05-30 | — | — | US | disclosed |
| EP-3169167-A1 | NUTRITIONAL COMPOSITIONS CONTAINING OIL BLENDS AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2017-05-24 | — | — | EP | disclosed |
| WO-2017083069-A1 | NUTRITIONAL COMPOSITIONS COMPRISING A CASEIN HYDROLYSATE, AS WELL AS DIETARY BUTYRATE AND/OR A COMPOUND FOR STIMULATING FORMATION OF ENDOGENOUS BUTYRATE | MJN U.S. HOLDINGS LLC (US) | 2017-05-18 | — | — | WO | disclosed |
| WO-2017083068-A1 | NUTRITIONAL COMPOSITIONS COMPRISING LACTOBACILLUS RHAMNOSUS GG, AS WELL AS DIETARY BUTYRATE AND/OR A COMPOUND FOR STIMULATING FORMATION OF ENDOGENOUS BUTYRATE | MJN U.S. HOLDINGS LLC (US) | 2017-05-18 | — | — | WO | disclosed |
| WO-2017083067-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2017-05-18 | — | — | WO | disclosed |
| WO-2017078907-A1 | NUTRITIONAL COMPOSITIONS FOR PROMOTING GUT BARRIER FUNCTION AND AMELIORATING VISCERAL PAIN | MJN U.S. HOLDINGS LLC (US) | 2017-05-11 | — | — | WO | disclosed |
| US-20170128500-A1 | NUTRITIONAL COMPOSITIONS FOR PROMOTING GUT BARRIER FUNCTION AND AMELIORATING VISCERAL PAIN | MEAD JOHNSON NUTRITION COMPANY | 2017-05-11 | — | — | US | disclosed |
| US-20170127693-A1 | NUTRITIONAL COMPOSITIONS CONTAINING BUTYRATE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2017-05-11 | — | — | US | disclosed |
| EP-3160482-A1 | LIPID COMPRISING DOCOSAPENTAENOIC ACID | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-05-03 | — | — | EP | disclosed |
| EP-3154376-A1 | PEDIATRIC NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES, PREBIOTICS AND PROBIOTICS | MJN U.S. Holdings, LLC (US) | 2017-04-19 | — | — | EP | disclosed |
| US-20170094991-A1 | INFANT FORMULA TABLETS | MEAD JOHNSON NUTRITION COMPANY | 2017-04-06 | — | — | US | disclosed |
| US-9609888-B2 | Nutritional compositions containing synergistic combination and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2017-04-04 | — | — | US | disclosed |
| EP-3139772-A1 | METHODS OF USE FOR PROBIOTICS AND PREBIOTICS | MJN U.S. Holdings, LLC (US) | 2017-03-15 | — | — | EP | disclosed |
| EP-3133940-A1 | NUTRITIONAL COMPOSITIONS DIRECTED TO SUBJECTS HAVING COW'S MILK PROTEIN ALLERGIES | MJN U.S. Holdings LLC (US) | 2017-03-01 | — | — | EP | disclosed |
| US-20170020950-A1 | METHODS FOR MODULATING KINASES | MEAD JOHNSON NUTRITION COMPANY | 2017-01-26 | — | — | US | disclosed |
| WO-2017014865-A1 | NUTRITIONAL COMPOSITIONS COMPRISING HYDROLYSED CASEIN | MJN U.S. HOLDINGS LLC (US) | 2017-01-26 | — | — | WO | disclosed |
| WO-2017011132-A1 | NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT | MJN U.S. HOLDINGS LLC (US) | 2017-01-19 | — | — | WO | disclosed |
| WO-2017011117-A1 | NUTRITIONAL COMPOSITIONS CONTAINING PHOSPHATIDYLETHANOLAMINE, SPHINGOMYELIN AND DOCOSAHEXAENOIC ACID | MJN U.S. HOLDINGS LLC (US) | 2017-01-19 | — | — | WO | disclosed |
| WO-2017011133-A1 | NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT | MJN U.S. HOLDINGS LLC (US) | 2017-01-19 | — | — | WO | disclosed |
| US-20170006897-A1 | NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT | MEAD JOHNSON NUTRITION COMPANY | 2017-01-12 | — | — | US | disclosed |
| US-20170006898-A1 | NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT | MEAD JOHNSON NUTRITION COMPANY | 2017-01-12 | — | — | US | disclosed |
| US-20170007629-A1 | NUTRITIONAL COMPOSITIONS CONTAINING PHOSPHATIDYLETHANOLAMINE, SPHINGOMYELIN AND DOCOSAHEXAENOIC ACID | MEAD JOHNSON NUTRITION COMPANY | 2017-01-12 | — | — | US | disclosed |
| EP-3113628-A1 | NUTRITIONAL COMPOSITIONS CONTAINING CERAMIDE | MJN U.S. Holdings, LLC (US) | 2017-01-11 | — | — | EP | disclosed |
| EP-3113631-A1 | PROBIOTIC STABILIZATION | MJN U.S. Holdings, LLC (US) | 2017-01-11 | — | — | EP | disclosed |
| EP-3102196-A1 | METHODS FOR PROMOTING NEURONAL DEVELOPMENT AND/OR HEALTH COMPRISING ADMINISTRATION OF A COMBINATION OF DOCOSAHEXAENOIC ACID AND ALPHA-LIPOIC ACID | MJN U.S. Holdings, LLC (US) | 2016-12-14 | — | — | EP | disclosed |
| EP-3102052-A1 | PEDIATRIC NUTRITIONAL COMPOSITION WITH MILK PEPTIDES FOR HEALTHY GROWTH AND DEVELOPMENT | MJN U.S. Holdings, LLC (US) | 2016-12-14 | — | — | EP | disclosed |
| WO-2016195888-A1 | NUTRITIONAL COMPOSITIONS CONTAINING AN ELEVATED LEVEL OF INOSITOL AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2016-12-08 | — | — | WO | disclosed |
| US-20160354323-A1 | NUTRITIONAL COMPOSITIONS CONTAINING AN ELEVATED LEVEL OF INOSITOL AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2016-12-08 | — | — | US | disclosed |
| US-20160353774-A1 | NUTRITIONAL COMPOSITIONS COMPRISING SPORE-FORMING PROBIOTICS | SECOND SIGHT MEDICAL PRODUCTS, INC. | 2016-12-08 | — | — | US | disclosed |
| US-9511173-B2 | Biocompatible, biodegradable polyurethane materials with controlled hydrophobic to hydrophilic ratio | DePuy Synthes Products, Inc. (US) | 2016-12-06 | — | — | US | disclosed |
| US-20160345611-A1 | RICE PROTEIN HYDROLYSATE BASED FORMULAS AND PRODUCTION THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2016-12-01 | — | — | US | disclosed |
| US-20160317567-A1 | COMPOSITIONS FOR ENHANCING IMMUNE FUNCTION IN A PEDIATRIC SUBJECT | MEAD JOHNSON NUTRITION COMPANY | 2016-11-03 | — | — | US | disclosed |
| EP-3079503-A1 | PROBIOTIC STABILIZATION | MJN U.S. Holdings, LLC (US) | 2016-10-19 | — | — | EP | disclosed |
| US-9457058-B2 | Nutritional composition containing a peptide component with anti-inflammatory properties and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-10-04 | — | — | US | disclosed |
| EP-3041372-A1 | NUTRITIONAL COMPOSITIONS FOR ENHANCING BRAIN DEVELOPMENT | MJN U.S. Holdings, LLC (US) | 2016-07-13 | — | — | EP | disclosed |
| US-9375028-B2 | Compositions and methods for nutrient delivery | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-06-28 | — | — | US | disclosed |
| US-20160177220-A1 | LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS AT THE SN-2 POSITION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-06-23 | — | — | US | disclosed |
| US-20160158304-A1 | Composition, and Method of Using the Composition, Effective for Minimizing the Harmful Effects Associated with Individuals Suffering from Alcohol Intoxication | BURN-OFF, LLC | 2016-06-09 | — | — | US | disclosed |
| EP-3027057-A1 | METHODS FOR PROMOTING NEURONAL DEVELOPMENT AND/OR HEALTH | MJN U.S. Holdings, LLC (US) | 2016-06-08 | — | — | EP | disclosed |
| US-9351978-B2 | Neurogenesis screening method and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-05-31 | — | — | US | disclosed |
| US-9345741-B2 | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-05-24 | — | — | US | disclosed |
| US-9345727-B2 | Nutritional compositions containing a peptide component and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-05-24 | — | — | US | disclosed |
| EP-3019036-A1 | COMPOSITIONS AND METHODS FOR NUTRIENT DELIVERY | MJN U.S. Holdings, LLC (US) | 2016-05-18 | — | — | EP | disclosed |
| US-20160129071-A1 | NUTRITIONAL SUPPLEMENTS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2016-05-12 | — | — | US | disclosed |
| WO-2016073126-A1 | NUTRITIONAL SUPPLEMENTS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2016-05-12 | — | — | WO | disclosed |
| WO-2016073132-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRIN AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2016-05-12 | — | — | WO | disclosed |
| WO-2016053563-A1 | NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE | MJN U.S. HOLDINGS LLC (US) | 2016-04-07 | — | — | WO | disclosed |
| US-20160095339-A1 | NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE | MEAD JOHNSON NUTRITION COMPANY | 2016-04-07 | — | — | US | disclosed |
| US-9301966-B2 | Nutritional compositions containing magnesium threonate and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| EP-2996491-A1 | NUTRITIONAL COMPOSITION COMPRISING WHEY AND HYDROLYZED CASEIN AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2016-03-23 | — | — | EP | disclosed |
| US-9282735-B2 | Use of EDDS and calcium ions as enchancers of molluscicidal activity | INNOSPEC LIMITED (GB) | 2016-03-15 | — | — | US | disclosed |
| EP-2986161-A1 | NUTRITIONAL COMPOSITION CONTAINING A PEPTIDE COMPONENT WITH ADIPONECTIN SIMULATING PROPERTIES AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2016-02-24 | — | — | EP | disclosed |
| EP-2986164-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2016-02-24 | — | — | EP | disclosed |
| EP-2983531-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT WITH ANTI-INFLAMMATORY PROPERTIES AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2016-02-17 | — | — | EP | disclosed |
| EP-2983520-A1 | NUTRITIONAL COMPOSITIONS CONTAINING STRUCTURED FAT GLOBULES AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2016-02-17 | — | — | EP | disclosed |
| EP-2983483-A1 | ANTI-REGURGITATION NUTRITIONAL COMPOSITION | MJN U.S. Holdings, LLC (US) | 2016-02-17 | — | — | EP | disclosed |
| EP-2983518-A1 | NUTRITIONAL COMPOSITIONS CONTAINING AN ENRICHED LIPID FRACTION AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2016-02-17 | — | — | EP | disclosed |
| WO-2016018533-A1 | HYDROLYZED LACTOSE-CONTAINING NUTRITIONAL COMPOSITIONS AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2016-02-04 | — | — | WO | disclosed |
| US-20160029682-A1 | HYDROLYZED LACTOSE-CONTAINING NUTRITIONAL COMPOSITIONS AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2016-02-04 | — | — | US | disclosed |
| US-9241923-B2 | Methods for promoting neuronal development and/or health | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-01-26 | — | — | US | disclosed |
| WO-2016010664-A1 | NUTRITIONAL COMPOSITIONS CONTAINING OIL BLENDS AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2016-01-21 | — | — | WO | disclosed |
| US-20160015068-A1 | NUTRITIONAL FORMULAS CONTAINING OIL BLENDS AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2016-01-21 | — | — | US | disclosed |
| US-9226914-B2 | Methods for promoting neuronal development and/or health | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-01-05 | — | — | US | disclosed |
| US-20150374597-A1 | DENTAL BLEACHING COMPOSITION | OSSTEMIMPLANT CO., LTD (KR) | 2015-12-31 | — | — | US | disclosed |
| US-20150374654-A1 | LIPID COMPRISING DOCOSAPENTAENOIC ACID | GRAINS RESEARCH AND DEVELOPMENT CORPORATION (AU) | 2015-12-31 | — | — | US | disclosed |
| EP-2958442-A1 | AMINO ACID AND PROTEIN HYDROLYSATE BASED FORMULAS WITH A STABLE EMULSION SYSTEM | MJN U.S. Holdings, LLC (US) | 2015-12-30 | — | — | EP | disclosed |
| WO-2015196250-A1 | LIPID COMPRISING DOCOSAPENTAENOIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-12-30 | — | — | WO | disclosed |
| EP-2957276-A1 | DENTAL BLEACHING COMPOSITION | Osstem Implant Co., Ltd. (KR) | 2015-12-23 | — | — | EP | disclosed |
| EP-2943081-A1 | NUTRITIONAL COMPOSITIONS CONTAINING MAGNESIUM THREONATE AND USES THEREOF | MJN U.S. Holdings LLC (US) | 2015-11-18 | — | — | EP | disclosed |
| EP-2943079-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A NEUROLOGIC COMPONENT AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2015-11-18 | — | — | EP | disclosed |
| US-9186350-B2 | Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication | GDB PATENT HOLDINGS, LLC (US) | 2015-11-17 | — | — | US | disclosed |
| US-20150305385-A1 | PEDIATRIC NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCAHRIDES, PREBIOTICS AND PROBIOTICS | MEAD JOHNSON NUTRITION COMPANY | 2015-10-29 | — | — | US | disclosed |
| US-20150305384-A1 | PEDIATRIC NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCAHRIDES, PREBIOTICS AND PROBIOTICS | MEAD JOHNSON NUTRITION COMPANY | 2015-10-29 | — | — | US | disclosed |
| WO-2015164020-A1 | NUTRITIONAL COMPOSITIONS DIRECTED TO SUBJECTS HAVING COW'S MILK PROTEIN ALLERGIES | MJN U.S. HOLDINGS LLC (US) | 2015-10-29 | — | — | WO | disclosed |
| WO-2015164021-A1 | PEDIATRIC NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES, PREBIOTICS AND PROBIOTICS | MJN U.S. HOLDINGS LLC (US) | 2015-10-29 | — | — | WO | disclosed |
| US-20150305359-A1 | NUTRITIONAL COMPOSITIONS DIRECTED TO SUBJECTS HAVING COW'S MILK PROTEIN ALLERGIES | MEAD JOHNSON NUTRITION COMPANY | 2015-10-29 | — | — | US | disclosed |
| EP-2934188-A1 | MILK-BASED NUTRITIONAL COMPOSITIONS CONTAINING LACTOFERRIN AND USES THEREOF | MJN U.S. Holdings, LLC (US) | 2015-10-28 | — | — | EP | disclosed |
| EP-2931064-A1 | NUTRITIONAL COMPOSITION FOR PROMOTING SATIETY | MJN U.S. Holdings, LLC (US) | 2015-10-21 | — | — | EP | disclosed |
| US-20150290261-A1 | METHODS OF USE FOR PROBIOTICS AND PREBIOTICS | MEAD JOHNSON NUTRITION COMPANY | 2015-10-15 | — | — | US | disclosed |
| WO-2015156942-A1 | METHODS OF USE FOR PROBIOTICS AND PREBIOTICS | MJN U.S. HOLDINGS LLC (US) | 2015-10-15 | — | — | WO | disclosed |
| US-20150290260-A1 | METHODS OF USE FOR PROBIOTICS AND PREBIOTICS | MEAD JOHNSON NUTRITION COMPANY | 2015-10-15 | — | — | US | disclosed |
| CN-104945162-A | Soilless cultivation nutrient formula of peonies and application thereof | TANG ZAIYING | 2015-09-30 | — | — | CN | disclosed |
| WO-2015134136-A1 | NUTRITIONAL COMPOSITIONS CONTAINING CERAMIDE | MJN U.S. HOLDINGS LLC (US) | 2015-09-11 | — | — | WO | disclosed |
| US-20150250220-A1 | NUTRITIONAL COMPOSITIONS CONTAINING CERAMIDE AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2015-09-10 | — | — | US | disclosed |
| US-20150237850-A1 | COMPOSITION, METHOD AND USE | W. NEUDORFF GMBH KG (DE) | 2015-08-27 | — | — | US | disclosed |
| US-20150231213-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRIN AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2015-08-20 | — | — | US | disclosed |
| US-20150231305-A1 | Biocompatible, Biodegradable Polyurethane Materials With Controlled Hydrophobic to Hydrophilic Ratio | DEPUY SYNTHES PRODUCTS INC (US) | 2015-08-20 | — | — | US | disclosed |
| EP-2389065-B1 | USE OF EDDS AND CALCIUM IONS AS ENHANCERS OF MOLLUSCICIDAL ACTIVITY | INNOSPEC LTD (GB) | 2015-08-19 | — | — | EP | disclosed |
| US-9089157-B2 | Adherence inhibition of pathogens by prebiotic oligosaccharides | MEAD JOHNSON NUTRITION COMPANY (US) | 2015-07-28 | — | — | US | disclosed |
| WO-2015105616-A1 | PEDIATRIC NUTRITIONAL COMPOSITION WITH MILK PEPTIDES FOR HEALTHY GROWTH AND DEVELOPMENT | MJN U.S. HOLDINGS LLC (US) | 2015-07-16 | — | — | WO | disclosed |
| US-20150189905-A1 | PEDIATRIC NUTRITIONAL COMPOSITION WITH MILK PEPTIDES FOR HEALTHY GROWTH AND DEVELOPMENT | MEAD JOHNSON NUTRITION COMPANY | 2015-07-09 | — | — | US | disclosed |
| WO-2015094533-A1 | NUTRITIONAL COMPOSITION CONTAINING A NEUROLOGIC COMPONENT OF URSOLIC ACID | MJN U.S. HOLDINGS LLC (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015094532-A1 | NUTRITIONAL COMPOSITION CONTAINING A NEUROLOGIC COMPONENT OF KAEMPFEROL AND/OR FISETIN | MJN U.S. HOLDINGS LLC (US) | 2015-06-25 | — | — | WO | disclosed |
| US-9061089-B2 | Biocompatible, biodegradable polyurethane materials with controlled hydrophobic to hydrophilic ratio | DePuy Synthes Products, Inc. (US) | 2015-06-23 | — | — | US | disclosed |
| WO-2015088706-A1 | NUTRITIONAL COMPOSITIONS CONTAINING STEARIDONIC ACID AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2015-06-18 | — | — | WO | disclosed |
| US-20150164833-A1 | NUTRITIONAL COMPOSITION CONTAINING A NEUROLOGIC COMPONENT OF URSOLIC ACID AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2015-06-18 | — | — | US | disclosed |
| US-20150157048-A1 | NUTRITIONAL COMPOSITIONS CONTAINING STEARIDONIC ACID AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2015-06-11 | — | — | US | disclosed |
| WO-2015084531-A1 | PROBIOTIC STABILIZATION | MJN U.S. HOLDINGS LLC (US) | 2015-06-11 | — | — | WO | disclosed |
| WO-2015084532-A1 | PROBIOTIC STABILIZATION | MJN U.S. HOLDINGS LLC (US) | 2015-06-11 | — | — | WO | disclosed |
| EP-2879508-A1 | NUTRITIONAL CREAMER COMPOSITION | MJN U.S. Holdings, LLC (US) | 2015-06-10 | — | — | EP | disclosed |
| US-9044009-B2 | Use of EDDS and calcium ions as enhancers of molluscicidal activity | W.NEUDORFF GMBH KG (DE) | 2015-06-02 | — | — | US | disclosed |
| US-20150125570-A1 | MILK-BASED NUTRITIONAL COMPOSITIONS CONTAINING LACTOFERRIN AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2015-05-07 | — | — | US | disclosed |
| US-20150119322-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRIN AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2015-04-30 | — | — | US | disclosed |
| EP-2863761-A1 | DIETARY MANAGEMENT OF CELIAC DISEASE AND FOOD ALLERGY | MJN U.S. Holdings, LLC (US) | 2015-04-29 | — | — | EP | disclosed |
| WO-2015050744-A2 | NEUROGENESIS SCREENING METHOD AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2015-04-09 | — | — | WO | disclosed |
| US-20150093463-A1 | NUTRITIONAL COMPOSITION CONTAINING A PEPTIDE COMPONENT WITH ANTI-INFLAMMATORY PROPERTIES AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2015-04-02 | — | — | US | disclosed |
| US-8986769-B2 | Methods for preserving endogenous TGF-β | MEAD JOHNSON NUTRITION COMPANY (US) | 2015-03-24 | — | — | US | disclosed |
| US-20150064222-A1 | NUTRITIONAL COMPOSITIONS FOR ENHANCING IMMUNE FUNCTION | MEAD JOHNSON NUTRITION COMPANY | 2015-03-05 | — | — | US | disclosed |
| US-8968722-B2 | Milk-based nutritional compositions containing lactoferrin and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2015-03-03 | — | — | US | disclosed |
| WO-2015017073-A1 | NUTRITIONAL COMPOSITIONS FOR ENHANCING BRAIN DEVELOPMENT | MJN U.S. HOLDINGS LLC (US) | 2015-02-05 | — | — | WO | disclosed |
| US-20150037455-A1 | NUTRITIONAL COMPOSITIONS CONTAINING SYNERGISTIC COMBINATION AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2015-02-05 | — | — | US | disclosed |
| WO-2015009406-A1 | METHODS FOR PROMOTING NEURONAL DEVELOPMENT AND/OR HEALTH | MJN U.S. HOLDINGS LLC (US) | 2015-01-22 | — | — | WO | disclosed |
| WO-2015009407-A1 | METHODS FOR PROMOTING NEURONAL DEVELOPMENT AND/OR HEALTH COMPRISING ADMINISTRATION OF A COMBINATION OF DOCOSAHEXAENOIC ACID AND ALPHA-LIPOIC ACID | MJN U.S. HOLDINGS LLC (US) | 2015-01-22 | — | — | WO | disclosed |
| US-20150023922-A1 | METHODS FOR PROMOTING NEURONAL DEVELOPMENT AND/OR HEALTH | MEAD JOHNSON NUTRITION COMPANY | 2015-01-22 | — | — | US | disclosed |
| US-20150023923-A1 | METHODS FOR PROMOTING NEURONAL DEVELOPMENT AND/OR HEALTH | MEAD JOHNSON NUTRITION COMPANY | 2015-01-22 | — | — | US | disclosed |
| US-20140378419-A1 | Compositions and Methods for Nutrient Delivery | MEAD JOHNSON NUTRITION COMPANY | 2014-12-25 | — | — | US | disclosed |
| WO-2014204621-A1 | COMPOSITIONS AND METHODS FOR NUTRIENT DELIVERY | MJN U.S. HOLDINGS LLC (US) | 2014-12-24 | — | — | WO | disclosed |
| US-8889633-B2 | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| US-20140335229-A1 | GLYCEROL DERIVED MATERIAL | BIO-ENERGY INGREDIENTS LIMITED (GB) | 2014-11-13 | — | — | US | disclosed |
| WO-2014178992-A1 | NUTRITIONAL COMPOSITION COMPRISING WHEY AND HYDROLYZED CASEIN AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-11-06 | — | — | WO | disclosed |
| WO-2014179053-A1 | NUTRITIONAL COMPOSITION COMPRISING WHEY AND HYDROLYZED CASEIN AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20140328970-A1 | Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof | MEAD JOHNSON NUTRITION COMPANY | 2014-11-06 | — | — | US | disclosed |
| US-8858920-B2 | Anti-caries oral care composition with xylitol | COLGATE-PALMOLIVE COMPANY (US) | 2014-10-14 | — | — | US | disclosed |
| WO-2014150557-A1 | NUTRITIONAL COMPOSITION CONTAINING A PEPTIDE COMPONENT WITH ADIPONECTIN SIMULATING PROPERTIES AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014150558-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT WITH ANTI-INFLAMMATORY PROPERTIES AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014150556-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014143523-A1 | NUTRITIONAL COMPOSITIONS CONTAINING STRUCTURED FAT GLOBULES AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014143470-A1 | NUTRITIONAL COMPOSITIONS CONTAINING STRUCTURED FAT GLOBULES AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014143480-A1 | ANTI-REGURGITATION NUTRITIONAL COMPOSITION | MJN U.S. HOLDINGS LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014143469-A1 | NUTRITIONAL COMPOSITIONS CONTAINING AN ENRICHED LIPID FRACTION AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140271586-A1 | Nutritional Composition Containing a Peptide Component with Adiponectin Simulating Properties and Uses Thereof | Mead Johnson Nutrition (Asia Pacific) Pte. Ltd. (SG) | 2014-09-18 | — | — | US | disclosed |
| US-20140271553-A1 | Nutritional Compositions Containing A Peptide Component with Anti-Inflammatory Properties and Uses Thereof | Mead Johnson Nutrition (Asia Pacifci) Pte. Ltd. (SG) | 2014-09-18 | — | — | US | disclosed |
| US-20140271552-A1 | Nutritional Compositions Containing a Peptide Component and Uses Thereof | MEAD JOHNSON NUTRITION COMPANY | 2014-09-18 | — | — | US | disclosed |
| US-20140271979-A1 | ANTI-REGURGITATION NUTRITIONAL COMPOSITION | MEAD JOHNSON NUTRITION COMPANY | 2014-09-18 | — | — | US | disclosed |
| US-20140255538-A1 | Nutritional Compositions Containing Structured Fat Globules and Uses Thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2014-09-11 | — | — | US | disclosed |
| US-20140255537-A1 | Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof | MEAD JOHNSON NUTRITION COMPANY | 2014-09-11 | — | — | US | disclosed |
| US-20140255539-A1 | Nutritional Compositions Containing Structured Fat Globules and Uses Thereof | MEAD JOHNSON NUTRITION COMPANY (US) | 2014-09-11 | — | — | US | disclosed |
| US-8822737-B2 | Glycerol derived material | BIO-ENERGY INGREDIENTS LIMITED (GB) | 2014-09-02 | — | — | US | disclosed |
| US-20140242216-A1 | Amino Acid And Protein Hydrolysate Based Formulas With A Stable Emulsion System | MEAD JOHNSON NUTRITION COMPANY (US) | 2014-08-28 | — | — | US | disclosed |
| WO-2014130200-A1 | AMINO ACID AND PROTEIN HYDROLYSATE BASED FORMULAS WITH A STABLE EMULSION SYSTEM | MJN U.S. HOLDINGS LLC (US) | 2014-08-28 | — | — | WO | disclosed |
| EP-2765870-A1 | NUTRITIONAL PHYTONUTRIENT COMPOSITIONS | MJN U.S. Holdings LLC (US) | 2014-08-20 | — | — | EP | disclosed |
| EP-2765871-A1 | COMPOSITION AND METHOD OF PHYTONUTRIENTS FOR METABOLIC PROGRAMMING EFFECTS | MJN U.S. Holdings LLC (US) | 2014-08-20 | — | — | EP | disclosed |
| WO-2014109862-A1 | NUTRITIONAL COMPOSITIONS CONTAINING A NEUROLOGIC COMPONENT AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-07-17 | — | — | WO | disclosed |
| WO-2014109863-A1 | NUTRITIONAL COMPOSITIONS CONTAINING MAGNESIUM THREONATE AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-07-17 | — | — | WO | disclosed |
| US-20140179775-A1 | NEUROGENESIS SCREENING METHOD AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2014-06-26 | — | — | US | disclosed |
| US-20140179782-A1 | NEUROGENESIS SCREENING METHOD AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2014-06-26 | — | — | US | disclosed |
| US-20140179656-A1 | NEUROGENESIS SCREENING METHOD AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY | 2014-06-26 | — | — | US | disclosed |
| WO-2014099134-A1 | MILK-BASED NUTRITIONAL COMPOSITIONS CONTAINING LACTOFERRIN AND USES THEREOF | MJN U.S. HOLDINGS LLC (US) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014092861-A1 | NUTRITIONAL COMPOSITION FOR PROMOTING SATIETY | MJN U.S. HOLDINGS LLC (US) | 2014-06-19 | — | — | WO | disclosed |
| US-20140170259-A1 | NUTRITIONAL COMPOSITION FOR PROMOTING SATIETY | MEAD JOHNSON NUTRITION COMPANY (US) | 2014-06-19 | — | — | US | disclosed |
| US-20140170265-A1 | INFANT FORMULA CUBES | MEAD JOHNSON NUTRITION COMPANY (US) | 2014-06-19 | — | — | US | disclosed |
| US-20140066523-A1 | Drug Delivery Compositions And Methods Of Use | ABYRX, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| WO-2014022051-A1 | NUTRITIONAL CREAMER COMPOSITION | MJN U.S. HOLDINGS LLC (US) | 2014-02-06 | — | — | WO | disclosed |
| US-20140037813-A1 | NUTRITIONAL CREAMER COMPOSITION | MEAD JOHNSON NUTRITION COMPANY (US) | 2014-02-06 | — | — | US | disclosed |
| US-20140023725-A1 | Biocompatible, Biodegradable Polyurethane Materials With Controlled Hydrophobic to Hydrophilic Ratio | DePuy Synthes Products, LLC (US) | 2014-01-23 | — | — | US | disclosed |
| WO-2013191845-A1 | DIETARY MANAGEMENT OF CELIAC DISEASE AND FOOD ALLERGY | MJN U.S. HOLDINGS LLC (US) | 2013-12-27 | — | — | WO | disclosed |
| US-20130344042-A1 | DIETARY MANAGEMENT OF CELIAC DISEASE AND FOOD ALLERGY | MEAD JOHNSON NUTRITION COMPANY | 2013-12-26 | — | — | US | disclosed |
| US-20130287895-A1 | ADHERENCE INHIBITION OF PATHOGENS BY PREBIOTIC OLIGOSACCHARIDES | MEAD JOHNSON NUTRITION COMPANY (US) | 2013-10-31 | — | — | US | disclosed |
| EP-2323964-B1 | METHOD OF PRODUCING A SOLID GLYCEROL DERIVED MATERIAL | BIO ENERGY INGREDIENTS LTD (GB) | 2013-10-23 | — | — | EP | disclosed |
| EP-2648549-A1 | COMPOSITIONS AND METHODS FOR NUTRIENT DELIVERY | MJN U.S. Holdings LLC (US) | 2013-10-16 | — | — | EP | disclosed |
| US-20130150306-A1 | MILK-BASED NUTRITIONAL COMPOSITIONS CONTAINING LACTOFERRIN AND USES THEREOF | MEAD JOHNSON NUTRITION COMPANY (US) | 2013-06-13 | — | — | US | disclosed |
| US-8460378-B2 | Use as scaffolds, tissue engineering, bone repair, drug delivery; polyurethane derived from biocompatible biodegradable polyols, polyisocyanates, and low molecular weight chain extenders having functionality of two or higher; can be derived from sugar or soy-based ingredients | DePuy Sythes Products, LLC (US) | 2013-06-11 | — | — | US | disclosed |
| US-8425955-B2 | Nutritional composition with prebiotic component | MEAD JOHNSON NUTRITION COMPANY (US) | 2013-04-23 | — | — | US | disclosed |
| US-20130095204-A1 | NUTRITIONAL PHYTONUTRIENT COMPOSITIONS | MEAD JOHNSON NUTRITION COMPANY | 2013-04-18 | — | — | US | disclosed |
| WO-2013055444-A1 | COMPOSITION AND METHOD OF PHYTONUTRIENTS FOR METABOLIC PROGRAMMING EFFECTS | MEAD JOHNSON NUTRITION COMPANY (US) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013055439-A1 | NUTRITIONAL PHYTONUTRIENT COMPOSITIONS | MEAD JOHNSON NUTRITION COMPANY (US) | 2013-04-18 | — | — | WO | disclosed |
| US-20130095189-A1 | COMPOSITION AND METHOD OF PHYTONUTRIENTS FOR METABOLIC PROGRAMMING EFFECTS | MEAD JOHNSON NUTRITION COMPANY | 2013-04-18 | — | — | US | disclosed |
| EP-2574237-A1 | Use of a lipoteichoic acid, mono- or polyglycerophosphate for antibacterial pre-treatment and especially in medical devices | Lunamed AG (CH) | 2013-04-03 | — | — | EP | disclosed |
| US-20130078194-A1 | COMPOSITIONS FOR DENTAL TREATMENT COMPRISING LIPOTEICHOIC ACIDS OR PARTS THEREOF LIKE MONO- OR POLYGLYCERPHOSPHATES | LUNAMED AG (CH) | 2013-03-28 | — | — | US | disclosed |
| EP-2552427-A1 | COMPOSITIONS FOR DENTAL TREATMENT COMPRISING LIPOTEICHOIC ACIDS OR PARTS THEREOF LIKE MONO- OR POLYGLYCERPHOSPHATES | Lunamed AG (CH) | 2013-02-06 | — | — | EP | disclosed |
| US-20130017276-A1 | Composition, and Method of Using the Composition, Effective for Minimizing the Harmful Effects Associated with Individuals Suffering from Alcohol Intoxication | GDB PATENT HOLDINGS, LLC | 2013-01-17 | — | — | US | disclosed |
| WO-2013009997-A1 | COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATED WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION | BURN-OFF, LLC (US) | 2013-01-17 | — | — | WO | disclosed |
| EP-2533652-A1 | NUTRITIONAL COMPOSITIONS | Mead Johnson Nutrition Company (US) | 2012-12-19 | — | — | EP | disclosed |
| WO-2012151196-A1 | DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | ORTHOCON, INC. (US) | 2012-11-08 | — | — | WO | disclosed |
| US-8263048-B2 | Calcium phosphate complex for oral care applications, its preparation method, and compositions containing the same | TAIPEI MEDICAL UNIVERSITY (TW) | 2012-09-11 | — | — | US | disclosed |
| US-20120165236-A1 | CLEANSING AGENT | SHOICHI NAKAMURA (JP) | 2012-06-28 | — | — | US | disclosed |
| WO-2012078358-A1 | COMPOSITIONS AND METHODS FOR NUTRIENT DELIVERY | MEAD JOHNSON NUTRITION COMPANY (US) | 2012-06-14 | — | — | WO | disclosed |
| US-20120149774-A1 | COMPOSITIONS AND METHODS FOR NUTRIENT DELIVERY | MEAD JOHNSON NUTRITION COMPANY | 2012-06-14 | — | — | US | disclosed |
| US-20120134936-A1 | Tooth Whitener | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2012-05-31 | — | — | US | disclosed |
| US-20120027832-A1 | USE OF EDDS AND CALCIUM IONS AS ENHANCERS OF MOLLUSCICIDAL ACTIVITY | W. NEUDORFF GMBH KG (DE) | 2012-02-02 | — | — | US | disclosed |
| US-8075934-B2 | Nutritional composition with improved digestibility | MEAD JOHNSON NUTRITION COMPANY (US) | 2011-12-13 | — | — | US | disclosed |
| WO-2011150337-A1 | NUTRITIONAL COMPOSITIONS | MEAD JOHNSON NUTRITION COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| US-20110293783-A1 | NUTRITIONAL COMPOSITIONS FOR ENHANCING IMMUNE FUNCTION | MEAD JOHNSON NUTRITION COMPANY | 2011-12-01 | — | — | US | disclosed |
| EP-2389065-A2 | USE OF EDDS AND CALCIUM IONS AS ENHACERS OF MOLLUSCICIDAL ACTIVITY | Innospec Limited (GB) | 2011-11-30 | — | — | EP | disclosed |
| US-20110256290-A1 | A GLYCEROL DERIVED MATERIAL | BIO-ENERGY INGREDIENTS LIMITED (GB) | 2011-10-20 | — | — | US | disclosed |
| WO-2011120707-A1 | COMPOSITIONS FOR DENTAL TREATMENT COMPRISING LIPOTEICHOIC ACIDS OR PARTS THEREOF LIKE MONO- OR POLYGLYCERPHOSPHATES | LUNAMED AG (CH) | 2011-10-06 | — | — | WO | disclosed |
| EP-2337450-A1 | METHODS FOR PRESERVING ENDOGENOUS TGF-BETA | Mead Johnson Nutrition Company (US) | 2011-06-29 | — | — | EP | disclosed |
| US-20110150791-A1 | CALCIUM PHOSPHATE COMPLEX FOR ORAL CARE APPLICATIONS, ITS PREPARATION METHOD, AND COMPOSITIONS CONTAINING THE SAME | TAIPEI MEDICAL UNIVERSITY (TW) | 2011-06-23 | — | — | US | disclosed |
| EP-2323964-A2 | A GLYCEROL DERIVED MATERIAL | Bio-Energy Ingredients Limited (GB) | 2011-05-25 | — | — | EP | disclosed |
| US-20100316619-A1 | NUTRITIONAL COMPOSITION WITH PREBIOTIC COMPONENT | MEAD JOHNSON NUTRITION COMPANY | 2010-12-16 | — | — | US | disclosed |
| WO-2010084361-A2 | COMPOSITION, METHOD AND USE | INNOSPEC LIMITED (GB) | 2010-07-29 | — | — | WO | disclosed |
| US-20100104727-A1 | Methods For Preserving Endogenous TGF-Beta | MEAD JOHNSON & CO. (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2010048474-A1 | METHODS FOR PRESERVING ENDOGENOUS TGF-BETA | MEAD JOHNSON NUTRITION COMPANY (US) | 2010-04-29 | — | — | WO | disclosed |
| US-20100104696-A1 | Nutritional Composition With Improved Digestibility | MEAD JOHNSON & CO. (US) | 2010-04-29 | — | — | US | disclosed |
| US-7666830-B2 | Nutritional composition preventing bacterial overgrowth | NESTEC S.A. (CH) | 2010-02-23 | — | — | US | disclosed |
| WO-2010004501-A2 | A GLYCEROL DERIVED MATERIAL | BIO-ENERGY INGREDIENTS LIMITED (GB) | 2010-01-14 | — | — | WO | disclosed |
| US-20090130190-A1 | Transdermal System for the Delivery of Sufentanil and Its Analogs | LABTEC GMBH (DE) | 2009-05-21 | — | — | US | disclosed |
| EP-2023907-A1 | TRANSDERMAL DELIVERY SYSTEM COMPRISING SUFENTANIL AND ITS ANALOGUES | LABTEC GESELLSCHAFT FüR TECHNOLOGISCHE FORSCHUNG UND ENTWICKLUNG MBH (DE) | 2009-02-18 | — | — | EP | disclosed |
| US-20080261891-A1 | COMPOSITIONS AND METHODS FOR USING SYRINGOPEPTIN 25A AND RHAMNOLIPIDS | UTAH STATE UNIVERSITY (US) | 2008-10-23 | — | — | US | disclosed |
| US-20080262613-A1 | Biocompatible, Biodegradable Polyurethane Materials With Controlled Hydrophobic to Hydrophilic Ratio | SYNTHES USA, LLC | 2008-10-23 | — | — | US | disclosed |
| US-20080226566-A1 | USE OF POORLY WATER-SOLUBLE CALCIUM SALTS AND/OR THE COMPOSITES THEREOF | HENKEL AG & CO. KGAA (DE) | 2008-09-18 | — | — | US | disclosed |
| EP-1959764-A2 | NUTRITIONAL SUPPLEMENT CONTAINING LONG-CHAIN POLYUNSATURATED FATTY ACIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-08-27 | — | — | EP | disclosed |
| US-20080193392-A1 | Tooth Whitener | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2008-08-14 | — | — | US | disclosed |
| EP-1863438-A1 | TOOTH WHITENER | LG Household & Health Care Ltd. (KR) | 2007-12-12 | — | — | EP | disclosed |
| WO-2007121949-A1 | TRANSDERMAL DELIVERY SYSTEM COMPRISING SUFENTANIL AND ITS ANALOGUES | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH (DE) | 2007-11-01 | — | — | WO | disclosed |
| EP-1833455-A1 | ANTI-CARIES ORAL CARE COMPOSITION WITH XYLITOL | Colgate-Palmolive Company (US) | 2007-09-19 | — | — | EP | disclosed |
| EP-1827361-A1 | ANTI-CARIES ORAL CARE COMPOSITION WITH A CHELATING AGENT | Colgate-Palmolive Company (US) | 2007-09-05 | — | — | EP | disclosed |
| US-20070166411-A1 | Nutritional supplement containing long-chain polyunsaturated fatty acids | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070154411-A1 | Oral and dental care product | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2007-07-05 | — | — | US | disclosed |
| WO-2007070611-A2 | NUTRITIONAL SUPPLEMENT CONTAINING LONG-CHAIN POLYUNSATURATED FATTY ACIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070110880-A1 | Hypoallergenic animal food | SERENEGY, LLC (US) | 2007-05-17 | — | — | US | disclosed |
| EP-1414316-B1 | NUTRITIONAL COMPOSITION PREVENTING BACTERIAL OVERGROWTH | NESTLE SA (CH) | 2007-02-21 | — | — | EP | disclosed |
| US-20060286044-A1 | Anti-caries oral care composition with xylitol | COLGATE-PALMOLIVE COMPANY | 2006-12-21 | — | — | US | disclosed |
| WO-2006135601-A1 | COMPOSITION FOR THE MINERALIZATION OF DENTAL HARD TISSUES AND THE REDUCTION OF CARIES-INDUCIVE MICROFLORA | PELDYAK JOHN (US) | 2006-12-21 | — | — | WO | disclosed |
| US-20060280694-A1 | Composition for the mineralization of dental hard tissues and the reduction of caries-inducive microflora | PELDYAK JOHN | 2006-12-14 | — | — | US | disclosed |
| US-20060275223-A1 | Erythritol compositions for teeth and gums | XLEAR, INC. | 2006-12-07 | — | — | US | disclosed |
| WO-2006112998-A1 | LIQUID NUTRITIONAL PRODUCT TO SUPPLEMENT HUMAN MILK | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-10-26 | — | — | WO | disclosed |
| US-20060233915-A1 | Liquid nutritional product to supplement human milk | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-10-19 | — | — | US | disclosed |
| US-20060222602-A1 | Oral and dental hygiene product | HENKEL KOMMANDITGESELLSCHAFT BUF AKTIEN (HENKEL KGAA) (DE) | 2006-10-05 | — | — | US | disclosed |
| WO-2006098602-A1 | TOOTH WHITENER | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006068750-A1 | ANTI-CARIES ORAL CARE COMPOSITION WITH XYLITOL | COLGATE-PALMOLIVE COMPANY (US) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006068753-A1 | ANTI-CARIES ORAL CARE COMPOSITION WITH A CHELATING AGENT | COLGATE-PALMOLIVE COMPANY (US) | 2006-06-29 | — | — | WO | disclosed |
| US-20060134020-A1 | Anti-caries oral care composition with a chelating agent | COLGATE-PALMOLIVE COMPANY | 2006-06-22 | — | — | US | disclosed |
| US-6773744-B1 | Confectionary products, low fat chocolate and chocolate-like products and methods for making them | HERSHEY FOODS CORPORATION | 2004-08-10 | — | — | US | disclosed |
| EP-1414316-A1 | NUTRITIONAL COMPOSITION PREVENTING BACTERIAL OVERGROWTH | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2004-05-06 | — | — | EP | disclosed |
| WO-2003011055-A1 | NUTRITIONAL COMPOSITION PREVENTING BACTERIAL OVERGROWTH | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2003-02-13 | — | — | WO | disclosed |
| EP-1281325-A1 | Nutritional composition preventing bacterial overgrowth | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2003-02-05 | — | — | EP | disclosed |
| US-6495180-B1 | BAKED SEEDS HAVING ANTACID COATINGS COMPRISING POTTASIUM HYDROXIDE AND POLYETHYLENE GLYCOL, GUM ARABIC OR CARBOXYMETHYL CELLULOSE, USED TO PRODUCE BEVERAGES HAVING NEUTRAL PH | TAMER INTERNATIONAL, LTD. | 2002-12-17 | — | — | US | disclosed |
| EP-1123081-B1 | HARDENABLE CERAMIC HYDRAULIC CEMENT | SYNTHES AG (CH) | 2002-12-11 | — | — | EP | disclosed |
| US-6461632-B1 | Hardenable ceramic hydraulic cement | SYNTHES (U.S.A.) | 2002-10-08 | — | — | US | disclosed |
| EP-1123081-A1 | HARDENABLE CERAMIC HYDRAULIC CEMENT | SYNTHES AG Chur (CH) | 2001-08-16 | — | — | EP | disclosed |
| US-6162472-A | Nutritional formula for premature infants and method of making | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2000-12-19 | — | — | US | disclosed |
| US-6066342-A | ADMINISTERING CALCIUM CARBONATE, POTASSIUM HYDROXIDE AND MAGNESIUM HYDROXIDE TO NEUTRALIZE STOMACH ACIDS | TAMER INTERNATIONAL, LTD. (US) | 2000-05-23 | — | — | US | disclosed |
| WO-2000023123-A1 | HARDENABLE CERAMIC HYDRAULIC CEMENT | SYNTHES AG CHUR (CH) | 2000-04-27 | — | — | WO | disclosed |
| US-6045843-A | COATING COFFEE BEAN SURFACE WITH AN ACID NEUTRALIZER AND A WATER SOLUBLE COATING AGENT; SIDE EFFECT REDUCTION | TAMER INTERNATIONAL, INC. (US) | 2000-04-04 | — | — | US | disclosed |
| WO-1999062345-A1 | ACID REDUCED WHOLE BEAN COFFEE AND PROCESS | TAMER INTERNATIONAL, LTD. (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1998027818-A1 | ANTACID COMPOSITION | TAMER INTERNATIONAL, LTD. (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027818-A1 | ANTACID COMPOSITION | TAMER INTERNATIONAL, LTD. (US) | 1998-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (24 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190240283-A1 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | FABP2, FABP4, GPR119 | LMNA 4302/4885ALDH1A1 4338/4885THRB 2195/4885 |
| US-12637408-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | SCD, ELOVL3, DAGLA | LMNA 611/4885ALDH1A1 4269/4885THRB 2190/4885 |
| US-10251928-B2 | Nutritional supplements containing a peptide component and uses thereof | FABP2, FABP4, GPR119 | LMNA 4302/4885ALDH1A1 4338/4885THRB 2195/4885 |
| US-20230134622-A1 | TWO-PART DENTAL SEALANT, METHOD OF APPLYING WITH A SYRINGE DEVICE, AND KIT | MMAB, SRM, MAT2A | LMNA 1304/4885ALDH1A1 1037/4885THRB 3120/4885 |
| US-12529007-B2 | Lipid comprising docosapentaenoic | DAGLA, SCD, FADS2 | LMNA 2412/4885ALDH1A1 3413/4885THRB 3130/4885 |
| US-20210228315-A1 | HARDENABLE DENTAL COMPOSITIONS COMPRISING BASIC CORE MATERIAL ENCAPSULATED IN AN INORGANIC SHELL AND DISPENSING DEVICES THEREWITH | ALPG, ALPP, ALPL | LMNA 416/4885ALDH1A1 2369/4885THRB 3915/4885 |
| US-20130078194-A1 | COMPOSITIONS FOR DENTAL TREATMENT COMPRISING LIPOTEICHOIC ACIDS OR PARTS THEREOF LIKE MONO- OR POLYGLYCERPHOSPHATES | PGLS, DDOST, PHOSPHO1 | LMNA 1782/4885ALDH1A1 3380/4885THRB 2283/4885 |
| US-20240423755-A1 | Two-Part Dental Sealant, Method of Applying with a Syringe Device, and Kit | MAT2A, MMAB, KIT | LMNA 1542/4885ALDH1A1 982/4885THRB 2905/4885 |
| US-20260117315-A1 | KEY PREDOMINANT SPECIES OF GUT BACTERIA COLONIZING FARM-EXPOSED INFANTS | FABP2, IL5, FZD7 | LMNA 1537/4885ALDH1A1 4492/4885THRB 2446/4885 |
| US-20150237850-A1 | COMPOSITION, METHOD AND USE | IDUA, ATP2A3, ATP2A1 | LMNA 972/4885ALDH1A1 3649/4885THRB 4225/4885 |
| US-12161523-B2 | Hardenable dental compositions comprising basic core material encapsulated in an inorganic shell and dispensing devices therewith | ALPG, ALPP, ALPL | LMNA 456/4885ALDH1A1 2313/4885THRB 3918/4885 |
| US-11077166-B2 | Nutritional supplements containing a peptide component and uses thereof | FABP2, FABP4, GPR119 | LMNA 4302/4885ALDH1A1 4338/4885THRB 2195/4885 |
| US-10933114-B2 | Nutritional supplements containing a peptide component and uses thereof | FABP2, FABP4, GPR119 | LMNA 4302/4885ALDH1A1 4338/4885THRB 2195/4885 |
| US-10034937-B2 | Synergistic nutritional compositions and uses thereof | FABP2, LRBA, TSLP | LMNA 4478/4885ALDH1A1 3938/4885THRB 1603/4885 |
| US-20160129071-A1 | NUTRITIONAL SUPPLEMENTS CONTAINING A PEPTIDE COMPONENT AND USES THEREOF | FABP2, FABP4, GPR119 | LMNA 4302/4885ALDH1A1 4338/4885THRB 2195/4885 |
| US-20210244787-A9 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | FABP2, FABP4, GPR119 | LMNA 4302/4885ALDH1A1 4338/4885THRB 2195/4885 |
| US-12102499-B2 | Two-part dental sealant, method of applying with a syringe device, and kit | MMAB, SRM, MAT2A | LMNA 1304/4885ALDH1A1 1037/4885THRB 3120/4885 |
| US-20260132353-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | ELOVL3, SCD, ELOVL6 | LMNA 971/4885ALDH1A1 3801/4885THRB 2664/4885 |
| US-20170157242-A1 | SYNERGISTIC NUTRITIONAL COMPOSITIONS AND USES THEREOF | FABP2, LRBA, TSLP | LMNA 4478/4885ALDH1A1 3938/4885THRB 1603/4885 |
| US-20080261891-A1 | COMPOSITIONS AND METHODS FOR USING SYRINGOPEPTIN 25A AND RHAMNOLIPIDS | CHIA, SGPL1, RPS25 | LMNA 4618/4885ALDH1A1 4405/4885THRB 4241/4885 |
| US-20090130190-A1 | Transdermal System for the Delivery of Sufentanil and Its Analogs | OPRL1, LPXN, OPRK1 | LMNA 4588/4885ALDH1A1 1672/4885THRB 655/4885 |
| US-20120027832-A1 | USE OF EDDS AND CALCIUM IONS AS ENHANCERS OF MOLLUSCICIDAL ACTIVITY | ORAI1, ATP2A1, ACMSD | LMNA 2161/4885ALDH1A1 3593/4885THRB 4183/4885 |
| US-20250064555-A1 | Hardenable Dental Compositions Comprising Basic Core Material Encapsulated in an Inorganic Shell and Dispensing Devices Therewith | ALPG, ALPP, ALPL | LMNA 456/4885ALDH1A1 2313/4885THRB 3918/4885 |
| US-20190224273-A1 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | FABP2, FABP4, GPR119 | LMNA 4302/4885ALDH1A1 4338/4885THRB 2195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.